Last Price$59.76.8%
Market Cap$3,532.4M
1M Return
61.5%
vs (8.2%) S&P 500
YTD Return
155.1%
vs 17.5% S&P 500
1Y Return
98.3%
vs 8.9% S&P 500
3Y Return
134.2%
vs 32.5% S&P 500
PTGX Momentum Rating
PTGX Momentum rating
8.1
PTGX Momentum rating performance
PTGX Price Performance and Momentum
Crunching data... Almost there!
Competing with PTGX Stock Price Performance
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Momentum score | Last Price | 52w high | 52w low | 1d change | 1w change | 1m change | 3m change | 6m change | 1y change | 3y change | 5y change | 10y change | 3y CAGR | 5y CAGR | 10y CAGR | % of 52w high | % of 52w low |
$3,532.4M | 8.1 | $59.7 6.8% | $59.7 | $24.7 | 6.8% | 54.5% | 61.5% | 45.7% | 33.4% | 98.3% | 134.2% | 734.4% | 410.6% | 32.8% | 52.9% | 22.6% | 100.0% | 242.3% | |
$124.8B | 3.0 | $488.3 (2.3%) | $516.7 | $392.8 | (2.3%) | 0.4% | 7.3% | 4.3% | 2.9% | 17.8% | 106.5% | 121.6% | 298.2% | 27.3% | 17.3% | 14.8% | 94.5% | 124.3% | |
$77.0B | 4.1 | $718.2 (3.6%) | $1,200.2 | $663.0 | (3.6%) | 6.3% | 8.1% | (7.0%) | (37.0%) | (25.4%) | 11.9% | 54.7% | 69.4% | 3.8% | 9.1% | 5.4% | 59.8% | 108.3% | |
$34.4B | 9.1 | $580.4 1.7% | $671.8 | $356.0 | 1.7% | (6.6%) | (8.7%) | (4.2%) | 8.0% | 50.8% | 108.6% | 333.8% | 2,423.6% | 27.8% | 34.1% | 58.6% | 86.4% | 163.0% | |
$30.7B | 4.6 | $238.7 2.4% | $300.6 | $143.3 | 2.4% | (1.7%) | (11.2%) | (6.1%) | (8.8%) | 60.1% | 54.1% | 134.3% | 110.2% | 15.5% | 18.6% | 7.7% | 79.4% | 166.6% | |
$24.0B | 5.8 | $98.4 (6.6%) | $126.9 | $78.4 | (6.6%) | (10.3%) | (14.1%) | (17.6%) | (0.9%) | 2.2% | (26.5%) | 209.9% | 600.1% | (9.8%) | 25.4% | 47.6% | 77.5% | 125.6% | |
$14.5B | 2.3 | $32.5 (0.9%) | $33.9 | $24.1 | (0.9%) | (2.6%) | 1.3% | 29.7% | 18.6% | 11.2% | (8.4%) | (19.0%) | (19.0%) | (2.9%) | (5.1%) | (5.1%) | 95.9% | 134.6% | |
$13.8B | 7.5 | $304.4 (4.2%) | $410.0 | $228.3 | (4.2%) | (1.4%) | (13.8%) | (15.9%) | (12.1%) | 22.0% | 76.0% | 223.9% | 86.9% | 20.7% | 26.5% | 6.5% | 74.2% | 133.4% | |
$13.4B | 3.4 | $70.5 (2.1%) | $93.8 | $61.3 | (2.1%) | (0.0%) | 10.9% | 6.9% | (16.9%) | (18.0%) | (7.2%) | (18.9%) | (38.4%) | (2.5%) | (4.1%) | (4.7%) | 75.1% | 115.1% | |
$13.3B | 8.0 | $18.5 2.8% | $31.9 | $2.4 | 2.8% | (3.1%) | (3.0%) | (1.4%) | (18.5%) | 330.2% | 563.1% | 878.8% | 68.3% | 87.9% | 57.8% | 5.3% | 57.9% | 774.1% | |
$1,846.9M | 9.0 | $226.7 0.0% | $246.0 | $129.5 | 0.0% | 2.0% | 23.3% | 4.7% | 40.9% | 39.9% | (6.5%) | 45.2% | 700.5% | (3.3%) | 7.7% | 29.7% | 92.1% | 175.0% |
FAQ
1. What is Protagonist Therapeutics, Inc. (PTGX) 1-month return?
Protagonist Therapeutics, Inc. (PTGX) 1-month return is 61.5%, compared to the (8.2%) return of the S&P 500.
2. What is Protagonist Therapeutics, Inc. (PTGX) year-to-date (YTD) return?
Protagonist Therapeutics, Inc. (PTGX) YTD return is 155.1%, compared to the 17.5% return of the S&P 500.
3. What is Protagonist Therapeutics, Inc. (PTGX) 1-year return?
Protagonist Therapeutics, Inc. (PTGX) 1-year return is 98.3%, compared to the 8.9% return of the S&P 500.
4. What is Protagonist Therapeutics, Inc. (PTGX) 3-year return?
Protagonist Therapeutics, Inc. (PTGX) 3-year return is 134.2%, compared to the 32.5% return of the S&P 500.